254 related articles for article (PubMed ID: 17967717)
1. Inflammatory molecules: a target for treatment of systemic autoimmune diseases.
Tincani A; Andreoli L; Bazzani C; Bosisio D; Sozzani S
Autoimmun Rev; 2007 Nov; 7(1):1-7. PubMed ID: 17967717
[TBL] [Abstract][Full Text] [Related]
2. [Rheumatoid arthritis and cytokines].
Kaneko S; Kondo Y; Yokosawa M; Sumida T
Nihon Rinsho; 2016 Jun; 74(6):913-8. PubMed ID: 27311178
[TBL] [Abstract][Full Text] [Related]
3. Pro- and anti-inflammatory cytokines in rheumatoid arthritis.
Isomäki P; Punnonen J
Ann Med; 1997 Dec; 29(6):499-507. PubMed ID: 9562516
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies and fusion proteins and their complications: targeting B cells in autoimmune diseases.
Lee S; Ballow M
J Allergy Clin Immunol; 2010 Apr; 125(4):814-20. PubMed ID: 20371395
[TBL] [Abstract][Full Text] [Related]
5. Cytokine-modulating strategies and newer cytokine targets for arthritis therapy.
Venkatesha SH; Dudics S; Acharya B; Moudgil KD
Int J Mol Sci; 2014 Dec; 16(1):887-906. PubMed ID: 25561237
[TBL] [Abstract][Full Text] [Related]
6. Antibody-based therapies in systemic lupus erythematosus.
Iikuni N; La Cava A
Mini Rev Med Chem; 2009 Jun; 9(7):829-46. PubMed ID: 19519508
[TBL] [Abstract][Full Text] [Related]
7. Update on the role of Interleukin 17 in rheumatologic autoimmune diseases.
Konya C; Paz Z; Apostolidis SA; Tsokos GC
Cytokine; 2015 Oct; 75(2):207-15. PubMed ID: 26028353
[TBL] [Abstract][Full Text] [Related]
8. The novel interleukin-1 cytokine family members in inflammatory diseases.
Hahn M; Frey S; Hueber AJ
Curr Opin Rheumatol; 2017 Mar; 29(2):208-213. PubMed ID: 27926540
[TBL] [Abstract][Full Text] [Related]
9. Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy.
Silverman GJ; Weisman S
Arthritis Rheum; 2003 Jun; 48(6):1484-92. PubMed ID: 12794814
[No Abstract] [Full Text] [Related]
10. Antibody therapy for rheumatoid arthritis.
Taylor PC
Curr Opin Pharmacol; 2003 Jun; 3(3):323-8. PubMed ID: 12810200
[TBL] [Abstract][Full Text] [Related]
11. Rescuing CD4+CD25+ regulatory T-cell functions in rheumatoid arthritis by cytokine-targeted monoclonal antibody therapy.
Bayry J; Sibéril S; Triebel F; Tough DF; Kaveri SV
Drug Discov Today; 2007 Jul; 12(13-14):548-52. PubMed ID: 17631249
[TBL] [Abstract][Full Text] [Related]
12. Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease?
Feldmann M; Brennan FM; Paleolog E; Cope A; Taylor P; Williams R; Woody J; Maini RN
Novartis Found Symp; 2004; 256():53-69; discussion 69-73, 106-11, 266-9. PubMed ID: 15027483
[TBL] [Abstract][Full Text] [Related]
13. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
Eisenberg R; Albert D
Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
[TBL] [Abstract][Full Text] [Related]
14. Development of anti-TNF therapy for rheumatoid arthritis.
Feldmann M
Nat Rev Immunol; 2002 May; 2(5):364-71. PubMed ID: 12033742
[TBL] [Abstract][Full Text] [Related]
15. Cytokine panel and histopathological aspects in the systemic lupus erythematosus.
Avrămescu C; Biciuşcă V; Dăianu T; Turculeanu A; Bălăşoiu M; Popescu SN; Ionete O; Simionescu C
Rom J Morphol Embryol; 2010; 51(4):633-40. PubMed ID: 21103619
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.
Goldblatt F; Isenberg DA
Handb Exp Pharmacol; 2008; (181):163-81. PubMed ID: 18071946
[TBL] [Abstract][Full Text] [Related]
17. Effects of anti-CD4 antibodies on the release of IL-6 and TNF-alpha in whole blood samples from patients with systemic lupus erythematosus.
Brink I; Thiele B; Burmester GR; Trebeljahr G; Emmrich F; Hiepe F
Lupus; 1999; 8(9):723-30. PubMed ID: 10602444
[TBL] [Abstract][Full Text] [Related]
18. Targeting B cells in immune-mediated inflammatory disease: a comprehensive review of mechanisms of action and identification of biomarkers.
Dörner T; Kinnman N; Tak PP
Pharmacol Ther; 2010 Mar; 125(3):464-75. PubMed ID: 20097226
[TBL] [Abstract][Full Text] [Related]
19. [Monoclonal antibody therapy for rheumatoid arthritis].
Ishii T; Saeki Y
Nihon Rinsho; 2002 Mar; 60(3):551-5. PubMed ID: 11904972
[TBL] [Abstract][Full Text] [Related]
20. [B-cell depletion in the treatment of rheumatoid arthritis].
Feist E; Burmester GR; Dörner T
Z Rheumatol; 2003 Aug; 62(4):361-6. PubMed ID: 12928940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
